Nyhedsbrev
Tilmeld dig Innovationsfondens nyhedsbrev og få de seneste nyheder, søgemuligheder og arrangementer
| Titel Sortér faldende | Periode | Program | |
|---|---|---|---|
| ColiShield ColiShield: A food supplement for precision-balancing the gut microbiome and reducing risk of E. coli infections | 2022 - 2026 | Grand Solutions
|
|
|
ColiShield ColiShield: A food supplement for precision-balancing the gut microbiome and reducing risk of E. coli infections
Periode
2022 - 2026
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
74.59 Fondens investering
11,1 mio. Samlet budget
14,8 mio. Projektdeltagere
Technical University of Denmark, Bactolife ApS, University of Southern Denmark Projektleder
Bactolife A/S
Læs mere om projektet
| |||
| COMBAT COVID-19 COMBAT COVID-19 induced adult respiratory distress syndrome | 2020 - 2021 | Grand Solutions
|
|
|
COMBAT COVID-19 COMBAT COVID-19 induced adult respiratory distress syndrome
Periode
2020 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
73.44 Fondens investering
3,0 mio. Samlet budget
4,1 mio. Projektdeltagere
Copenhagen University Hospital (Rigshospitalet), Nordsjællands Hospital, Bispebjerg Hospital, Herlev Hospital, Hvidovre Hospital, BioPorto AS, Endothel Pharma ApS Projektleder
Region Hovedstaden
Læs mere om projektet
| |||
| Combat Septic Shock Induced Endotheliopathy (SHINE) - A Personalized Medicines Approach | 2018 - 2023 | Grand Solutions
|
|
|
Combat Septic Shock Induced Endotheliopathy (SHINE) - A Personalized Medicines Approach
Periode
2018 - 2023
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
64.9 Fondens investering
15,0 mio. Samlet budget
23,1 mio. Projektdeltagere
Copenhagen University Hospital (Rigshospitalet), Nordsjællands Hospital, Bispebjerg Hospital, Herlev Hospital, Hvidovre Hospital, BioPorto, Endothel Pharma ApS Projektleder
Region Hovedstaden
Læs mere om projektet
| |||
| COMBAT-TOX Combat TOXic Catecholamine Syndrome Induced Mortality | 2024 - 2029 | Grand Solutions
|
|
|
COMBAT-TOX Combat TOXic Catecholamine Syndrome Induced Mortality
Periode
2024 - 2029
Region
Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
74.16 Fondens investering
11,0 mio. Samlet budget
14,9 mio. Shock due to trauma, infection and heart attack affects 10 million patients in USA and EU annually. Prof. Johansson at Rigshospitalet has identified a subgroup (20%) of the shocked patients having TOXic catecholamine release to the blood resulting in acute heart failure with >80% mortality rate.
The shocked TOX patients can be identified by the biomarker succinic acid > 10nM in the blood enabling targeted treatment with beta1-selective blocker, which according to published observational data, will reduce mortality by 50%. A PCT application has been filed by Rigshospitalet concerning this[WO2022/233994 A1].
The TOX project will validate the 10nM cut-off level of succinic acid to identify TOX in 500 patients with septic shock by mass spectrometry using an existing biobank at Rigshospitalet.
A point-of-care biosensor will be developed at DTU Bioengineering that measure succinic acid in plasma in the required nM range to be used in a proof-of-concept trial in 200 TOX patients with septic shock evaluating the effect of beta1-selective blockers vs. placebo on 30-day mortality conducted at Copenhagen University Hospitals.
The result of the trial including a Health Technology Assessment conducted by VIVE will be used to implement the TOX test globally through license agreements, partnering or take-over with global diagnostic companies, and MoxieLab ApS, a spin-out from Rigshospitalet, now owning the IP. Roche Diagnostics has already shown interest in the technology.
Projektdeltagere
Copenhagen University Hospital (Rigshospitalet), Technical University of Denmark, Herlev Hospital, Nordsjællands Hospital, Bispebjerg Hospital, VIVE – Det Nationale Forsknings- og Analysecenter for Velfærd, MoxieLab ApS Projektleder
Læs mere om projektet
| |||
| COMETS - Co-Management of Energy and Transport Systems | 2015 - 2019 | Grand Solutions
|
|
|
COMETS - Co-Management of Energy and Transport Systems
Periode
2015 - 2019
Region
Program
Grand Solutions Fagområde
Energi, Klima og Miljø Investering
Percentage
75.28 Fondens investering
13,6 mio. Samlet budget
18,1 mio. Projektdeltagere
DTU Management Engineering, Roskilde University, E4SMA, DTU Transport, University College Cork, Dansk Energi, CONCITO, Danish Board of Technology, Danish Energy Agency Projektleder
Aktiv
Læs mere om projektet
| |||
| Community Health Innovation: Platform Development and New Models for Preventive Care | 2018 - 2020 | Grand Solutions
|
|
|
Community Health Innovation: Platform Development and New Models for Preventive Care
Periode
2018 - 2020
Region
Region Sjælland Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
70.35 Fondens investering
15,0 mio. Samlet budget
21,3 mio. Projektdeltagere
Region Zealand, Odsherred kommune, Copenhagen Business School, Roche Diagnostics A/S, University of Manchester, Technical University of Denmark, Urgent Agency Projektleder
Region Sjælland
Læs mere om projektet
| |||
| Cool-Data Flexible Cooling of Data Centers | 2020 - 2023 | Grand Solutions
|
|
|
Cool-Data Flexible Cooling of Data Centers
Periode
2020 - 2023
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Energi, Klima og Miljø Investering
Percentage
72.35 Fondens investering
13,3 mio. Samlet budget
18,4 mio. Projektdeltagere
Technical University of Denmark, Technical University of Denmark, Technical University of Denmark, Energy Cool ApS, GEV A/S, Purix ApS, Naviair, Center Denmark Drift ApS Projektleder
Danmarks Tekniske Universitet
Læs mere om projektet
| |||
| COORDICY: ICT-driven Coordination for Reaching 2020 Energy Efficiency Goals in Public and Commercial Buildings - 4106-00003B | 2015 - 2019 | Grand Solutions
|
|
|
COORDICY: ICT-driven Coordination for Reaching 2020 Energy Efficiency Goals in Public and Commercial Buildings - 4106-00003B
Periode
2015 - 2019
Region
Program
Grand Solutions Fagområde
Energi, Klima og Miljø Investering
Percentage
79.55 Fondens investering
18,6 mio. Samlet budget
23,3 mio. Projektdeltagere
University of Southern Denmark, University of California at Berkeley, Lawrence Berkeley National Laboratory, NASA Ames Sustainability Base, Danish Technological Institute, Insero Software, Municipality of Aarhus, Municipality of Odense, Green Tech Center, Odense University Hospital, Danish Cleantech Hub, Danish Building & Property Agency, Rambøll, Siemens, Saseco, Develco Products, Synergy Projektleder
Aktiv
Læs mere om projektet
| |||
| CoRal Danish Conversational and Read-aloud Speech Dataset | 2023 - 2025 | Grand Solutions
|
|
|
CoRal Danish Conversational and Read-aloud Speech Dataset
Periode
2023 - 2025
Region
Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
64.12 Fondens investering
14,2 mio. Samlet budget
22,2 mio. Speech technology (ST) is a growing industry, with an estimated annual compound growth of 16-19% in the next five years. The majority of ST development is targeted towards high-resource languages, such as English. Danish, as a low-resource language, risks falling behind technologically and missing revenue from this technology. Modern ST is based on ML algorithms, which require large amounts of data. Lack of Danish data is causing Danish ST to fall behind. The CoRal project will remedy this, by creating the first large-scale high-quality dataset consisting of 1,500 hours of transcribed Danish speech, both conversational and read-aloud, comparable in size to English state-of-the-art speech datasets, with eight models, incl. speech recognition and text-to-speech models. The dataset and models will be publicly available and enable use cases which were previously impossible even for some of the largest Danish companies e.g., ATP. Publicly available materials will be developed which will help companies implement the technology and allow SMEs to enter the area with minimal risk, as they can use models and data with almost no prior expertise. In addition, the project will ensure that the dataset represents all variants of spoken Danish, across regiolects, ethnolects, etc. This will allow authorities to provide speech services to all citizens, even marginalized demographics. The scale and diversity of the dataset will push Danish ST up to the highest standard commercially.
Projektdeltagere
The Alexandra Institute, University of Copenhagen, Digitaliseringsstyrelsen, Corti, Alvenir Projektleder
Læs mere om projektet
| |||
| CoronaLytics CoronaLytics: A 360 degree mobile/wearable data household approach to guide shared precision health and decision-making during the COVID-19 epidemic | 2020 - 2021 | Grand Solutions
|
|
|
CoronaLytics CoronaLytics: A 360 degree mobile/wearable data household approach to guide shared precision health and decision-making during the COVID-19 epidemic
Periode
2020 - 2021
Region
Region Midtjylland Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
70.25 Fondens investering
4,0 mio. Samlet budget
5,7 mio. Projektdeltagere
Aarhus University, Aarhus University, MedTech Innovation Consortium, Alexandra Instituttet, Teknologisk Institut Projektleder
Aarhus Universitet
Læs mere om projektet
| |||
| CoroNAT Development of monoclonal antibody therapy for COVID-19 | 2020 - 2021 | Grand Solutions
|
|
|
CoroNAT Development of monoclonal antibody therapy for COVID-19
Periode
2020 - 2021
Region
Region Midtjylland Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
51.05 Fondens investering
5,0 mio. Samlet budget
9,8 mio. Projektdeltagere
Aarhus University, Symphogen A/S Projektleder
Aarhus Universitet
Læs mere om projektet
| |||
| Covid-19 Early Warning Covid-19 Early Warning - Overvågning af Covid-19 smittespredning gennem primærsektoren og digital borger adfærd | 2020 - 2022 | Grand Solutions
|
|
|
Covid-19 Early Warning Covid-19 Early Warning - Overvågning af Covid-19 smittespredning gennem primærsektoren og digital borger adfærd
Periode
2020 - 2022
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
90 Fondens investering
4,8 mio. Samlet budget
5,3 mio. Projektdeltagere
Sundhed.dk, University of Southern Denmark, Statens Serum Institut Projektleder
Sundhed.dk
Læs mere om projektet
| |||
| Covid-19 O2matic Covid-19 Automatic oxygen therapy | 2020 - 2022 | Grand Solutions
|
|
|
Covid-19 O2matic Covid-19 Automatic oxygen therapy
Periode
2020 - 2022
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
57.14 Fondens investering
3,1 mio. Samlet budget
5,3 mio. Projektdeltagere
Hvidovre Hospital, O2matic ApS Projektleder
O2matic ApS
Læs mere om projektet
| |||
| COVID19-MITC Trial Nation COVID-19 Multiplying Infectious Disease Trial Capacity | 2020 - 2021 | Grand Solutions
|
|
|
COVID19-MITC Trial Nation COVID-19 Multiplying Infectious Disease Trial Capacity
Periode
2020 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
75 Fondens investering
4,9 mio. Samlet budget
6,6 mio. Projektdeltagere
Trial Nation, Region Midtjylland, Region Hovedstaden, Region Sjælland, Region Nordjylland, Region Syddanmark Projektleder
Trial Nation
Læs mere om projektet
| |||
| COVIDtrace Prevention of COVID-19 transmission among patients and healthcare workers in hospitals and nursing homes using intelligent contact tracing | 2020 - 2021 | Grand Solutions
|
|
|
COVIDtrace Prevention of COVID-19 transmission among patients and healthcare workers in hospitals and nursing homes using intelligent contact tracing
Periode
2020 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Ikke defineret Investering
Percentage
74.45 Fondens investering
2,8 mio. Samlet budget
3,7 mio. Projektdeltagere
Konduto ApS, Technical University of Denmark Projektleder
Konduto ApS
Læs mere om projektet
| |||